Funders · Entity Annotation Prototype (beta)

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: NIH T32 AI177324 ×

NIH T32 AI177324

This funder is selected. Its supporting articles are shown below.

NIH T32 AI1773241

Articles mentioning NIH T32 AI177324

1 articles · page 1 of 1

455 Treg-associated ICOS as a possible biomarker for PD-1 therapy resistance in melanoma patients

jitc · abstract · 2025-11-04 · 1 matching annotations

82.2%

NIH T32 AI177324 University of California Irvine melanoma nivolumab Chao Family Comprehensive Cancer Center ipilimumab PD-1 immunotherapy αPD-1

… Center (University of California Irvine). S.G. is supported by NIH T32 AI177324 and an NSF-GRFP fellowship 2235784.References Wolchok JD, et al…

Browse funders

NIH T32 AI177324

Articles mentioning NIH T32 AI177324

455 Treg-associated ICOS as a possible biomarker for PD-1 therapy resistance in melanoma patients